AAAAAA

   
Results: 1-15 |
Results: 15
Prognostic value of DNA quantification in early epithelial ovarian carcinoma
Authors: Valverde, JJ Martin, M Garcia-Asenjo, JA Casado, A Vidart, JA Diaz-Rubio, E
Citation: Jj. Valverde et al., Prognostic value of DNA quantification in early epithelial ovarian carcinoma, OBSTET GYN, 97(3), 2001, pp. 409-416
Spanish family study on hereditary breast and/or ovarian cancer: Analysis of the BRCA1 gene
Authors: de la Hoya, M Perez-Segura, P Van Orsouw, N Diaz-Rubio, E Caldes, T
Citation: M. De La Hoya et al., Spanish family study on hereditary breast and/or ovarian cancer: Analysis of the BRCA1 gene, INT J CANC, 91(1), 2001, pp. 137-140
Low frequency of microsatellite instability in sporadic breast cancer
Authors: Caldes, T Perez-Segura, P Tosar, A De la Hoya, M Diaz-Rubio, E
Citation: T. Caldes et al., Low frequency of microsatellite instability in sporadic breast cancer, INT J ONCOL, 16(6), 2000, pp. 1235-1242
Cost-effectiveness analysis of interferon as adjuvant therapy in high-riskmelanoma patients in Spain
Authors: Gonzalez-Larriba, JL Serrano, S Alvarez-Mon, M Camacho, F Casado, MA Diaz-Perez, JL Diaz-Rubio, E Fosbrook, L Guillem, V Lopez-Lopez, JJ Moreno-Nogueira, JA Toribio, J
Citation: Jl. Gonzalez-larriba et al., Cost-effectiveness analysis of interferon as adjuvant therapy in high-riskmelanoma patients in Spain, EUR J CANC, 36(18), 2000, pp. 2344-2352
Paclitaxel plus vinorelbine: An active regimen in metastatic breast cancerpatients with prior anthracycline exposure
Authors: Martin, M Lluch, A Casado, A Carbonero, IG de Paz, L Esteban, C Insa, A Alfonso, R Garcia-Conde, J Diaz-Rubio, E
Citation: M. Martin et al., Paclitaxel plus vinorelbine: An active regimen in metastatic breast cancerpatients with prior anthracycline exposure, ANN ONCOL, 11(1), 2000, pp. 85-89
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium
Authors: Bellmunt, J Guillem, V Paz-Ares, L Gonzalez-Larriba, JL Carles, J Batiste-Alentorn, E Saenz, A Lopez-Brea, M Font, A Nogue, M Bastus, R Climent, MA de la Cruz, JJ Albanell, J Banus, JM Gallardo, E Diaz-Rubio, E Cortes-Funes, H Baselga, J
Citation: J. Bellmunt et al., Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium, J CL ONCOL, 18(18), 2000, pp. 3247-3255
Methotrexate, uracil and tegafur, and leucovorin chemotherapy for patientswith breast cancer in progression after high-dose chemotherapy with peripheral blood progenitor cell transplant - A phase II study
Authors: Martin, M Casado, A Macias, JA Garcia-Carbonero, I Garcia-Saenz, JA Oruezabal, M Manrique, I Diaz-Rubio, E
Citation: M. Martin et al., Methotrexate, uracil and tegafur, and leucovorin chemotherapy for patientswith breast cancer in progression after high-dose chemotherapy with peripheral blood progenitor cell transplant - A phase II study, AM J CL ONC, 23(6), 2000, pp. 617-621
Microsatellite instability correlates with negative expression of estrogenand progesterone receptors in sporadic breast cancer
Authors: Caldes, T Perez-Segura, P Tosar, A de la Hoya, M Diaz-Rubio, E
Citation: T. Caldes et al., Microsatellite instability correlates with negative expression of estrogenand progesterone receptors in sporadic breast cancer, TER CAR MUT, 20(5), 2000, pp. 283-291
New mutation in the hMSH2 gene in a Spanish Muir-Torre syndrome
Authors: Caldes, T Godino, J Perez-Segura, P de la Hoya, M Diaz-Rubio, E Benito, M
Citation: T. Caldes et al., New mutation in the hMSH2 gene in a Spanish Muir-Torre syndrome, AM J GASTRO, 95(9), 2000, pp. 2389-2390
Retrospective evaluation of toxicity in three different schedules of adjuvant chemotherapy for patients with resected colorectal cancer
Authors: Sastre, J Navarro, M Aranda, E Fonseca, E Checa, T Alonso, MC Gallen, M Camps, C Anton, A Diaz-Rubio, E
Citation: J. Sastre et al., Retrospective evaluation of toxicity in three different schedules of adjuvant chemotherapy for patients with resected colorectal cancer, ONCOL REP, 6(6), 1999, pp. 1421-1424
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients
Authors: Diaz-Rubio, E Sastre, J Abad, A Navarro, M Aranda, E Carrato, A Gallen, M Marcuello, E Rifa, J Massuti, T Cervantes, A Anton, A Martos, CF
Citation: E. Diaz-rubio et al., UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients, ONCOLOGY-NY, 13(7), 1999, pp. 35-40
Denaturing gradient gel electrophoresis-based analysis of loss of heterozygosity distinguishes nonobvious, deleterious BRCA1 variants from nonpathogenic polymorphisms
Authors: de la Hoya, M Diaz-Rubio, E Caldes, T
Citation: M. De La Hoya et al., Denaturing gradient gel electrophoresis-based analysis of loss of heterozygosity distinguishes nonobvious, deleterious BRCA1 variants from nonpathogenic polymorphisms, CLIN CHEM, 45(11), 1999, pp. 2028-2030
Treatment of advanced gastric cancer: The new generation regimens
Authors: Diaz-Rubio, E Cervantes, A Garcia-Carbonero, I
Citation: E. Diaz-rubio et al., Treatment of advanced gastric cancer: The new generation regimens, PROG ANTI C, 2, 1999, pp. 235-250
End-stage acute hepatic failure as clinical presentation of liver metastases from breast cancer
Authors: Nieto, Y Alonso, JL Ayala, F Ortega, L Casado, A Martin, M Diaz-Rubio, E
Citation: Y. Nieto et al., End-stage acute hepatic failure as clinical presentation of liver metastases from breast cancer, TUMORI, 84(5), 1998, pp. 616-617
Treatment of advanced colorectal cancer with chemotherapy: the role of newdrugs
Authors: Diaz-Rubio, E Carbonero, IG
Citation: E. Diaz-rubio et Ig. Carbonero, Treatment of advanced colorectal cancer with chemotherapy: the role of newdrugs, EUROCANCER 98, 1998, pp. 81-83
Risultati: 1-15 |